Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05417789 |
| Title | Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) (TANGENT) |
| Acronym | TANGENT |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | SynOx Therapeutics Limited |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult | child |
| Covered Countries | USA | NLD | ITA | ESP |